From: lncRNA DLEU2 promotes gastric cancer progression through ETS2 via targeting miR-30a-5p
Clinicopathological parameters | n | DLEU2 expression | P |
---|---|---|---|
Gender | |||
 Male | 55 | 1.437 ± 0.0617 | 0.5541 |
 Female | 20 | 1.500 ± 0.0764 | |
Age (years) | |||
 < 60 | 33 | 1.507 ± 0.0731 | 0.8911 |
 ≥ 60 | 42 | 1.493 ± 0.0549 | |
Tumor diameter (cm) | |||
 < 5 | 31 | 1.473 ± 0.0727 | 0.1748 |
 ≥ 5 | 44 | 1.623 ± 0.0549 | |
Pathological grading | |||
 I–II | 23 | 1.406 ± 0.0632 | 0.0087* |
 III–IV | 52 | 2.067 ± 0.1004 | |
TNM staging | |||
 T1–T2 | 15 | 1.997 ± 0.1695 | 0.0382* |
 T3–T4 | 60 | 1.417 ± 0.0869 |